Skip to main content
. 2020 Mar 22;10(3):581. doi: 10.3390/nano10030581

Figure 4.

Figure 4

Comparison of HUVEC viability in the presence between aANGP-MCs and free form peptide as assessed by MTT assay. (a) Graph showing cell viability after treatment with aANGP without overnight starvation and (b) after treatment with aANGP with overnight starvation using 10 ng/mL of VEGF. (c) Viability results obtained after treatment with free form aANGP and (d) with aANGP-MCs after 24 and 48 h. Δ-Significance between the samples at 24 and 48 h. Values were expressed as mean ± SD, n = 3. Δ p < 0.05.